News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
86,877 Results
Type
Article (2700)
Company Profile (2)
Press Release (84175)
Section
Business (25357)
Career Advice (514)
Deals (5785)
Drug Delivery (4)
Drug Development (13094)
Employer Resources (27)
FDA (1748)
Job Trends (1761)
News (45672)
Policy (3772)
Tag
2024 Biotech Bay Standard (1)
Academia (221)
Accelerated approval (1)
Allergies (15)
Alliances (4660)
ALS (17)
Alzheimer's disease (321)
Antibody-drug conjugate (ADC) (11)
Approvals (1759)
Artificial intelligence (37)
Autoimmune disease (7)
Bankruptcy (70)
Best Places to Work (1619)
BIOSECURE Act (2)
Biosimilars (13)
Biotechnology (4)
Bladder cancer (29)
Brain cancer (5)
Breast cancer (27)
Cancer (410)
Cardiovascular disease (20)
Career advice (412)
Career pathing (3)
CAR-T (21)
Cell therapy (93)
Cervical cancer (4)
Clinical research (11094)
Collaboration (120)
Compensation (39)
Complete response letters (1)
COVID-19 (268)
CRISPR (3)
C-suite (40)
Cystic fibrosis (9)
Data (568)
Decentralized trials (1)
Denatured (3)
Depression (6)
Diabetes (46)
Diagnostics (912)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (8)
Drug discovery (16)
Drug pricing (4)
Duchenne muscular dystrophy (9)
Earnings (14150)
Editorial (7)
Employer branding (4)
Employer resources (28)
Events (15351)
Executive appointments (132)
FDA (1993)
Featured Employer (1)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (99)
Gene editing (11)
Generative AI (1)
Gene therapy (44)
GLP-1 (90)
Government (392)
Guidances (12)
Healthcare (2500)
IgA nephropathy (4)
Immunology and inflammation (14)
Indications (6)
Infectious disease (293)
Inflammatory bowel disease (23)
Inflation Reduction Act (2)
Influenza (13)
Intellectual property (30)
Interviews (122)
IPO (3686)
IRA (1)
Job creations (220)
Job search strategy (338)
Kidney cancer (4)
Labor market (2)
Layoffs (18)
Leadership (6)
Legal (718)
Liver cancer (10)
Lung cancer (63)
Lymphoma (26)
Management (11)
Manufacturing (45)
MASH (26)
Medical device (1930)
Medtech (1930)
Mergers & acquisitions (2301)
Metabolic disorders (119)
Multiple sclerosis (19)
NASH (7)
Neurodegenerative disease (13)
Neuropsychiatric disorders (3)
Neuroscience (431)
NextGen: Class of 2025 (656)
Non-profit (388)
Northern California (660)
Obesity (45)
Opinion (24)
Ovarian cancer (13)
Pain (18)
Pancreatic cancer (33)
Parkinson's disease (35)
Partnered (1)
Patents (79)
Patient recruitment (20)
Peanut (11)
People (6758)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase I (3626)
Phase II (5135)
Phase III (3397)
Pipeline (375)
Policy (27)
Postmarket research (209)
Preclinical (1397)
Press Release (3)
Prostate cancer (23)
Psychedelics (2)
Radiopharmaceuticals (44)
Rare diseases (73)
Real estate (374)
Recruiting (11)
Regulatory (2968)
Reports (3)
Research institute (182)
Resumes & cover letters (83)
Rett syndrome (3)
RSV (6)
Schizophrenia (16)
Series A (10)
Series B (4)
Sickle cell disease (9)
Southern California (590)
Spinal muscular atrophy (30)
Sponsored (1)
Startups (161)
Supply chain (11)
Tariffs (7)
The Weekly (13)
United States (5274)
Vaccines (85)
Venture capitalists (3)
Weight loss (17)
Women's health (1)
Worklife (3)
Date
Today (4)
Last 7 days (128)
Last 30 days (540)
Last 365 days (7282)
2025 (2180)
2024 (7791)
2023 (9107)
2022 (9211)
2021 (9651)
2020 (8809)
2019 (5895)
2018 (4109)
2017 (4345)
2016 (3313)
2015 (4408)
2014 (2694)
2013 (1860)
2012 (2016)
2011 (2114)
2010 (1844)
Location
Africa (108)
Alabama (11)
Arizona (15)
Arkansas (1)
Asia (4567)
Australia (689)
California (1522)
Canada (388)
China (56)
Colorado (48)
Connecticut (67)
Delaware (16)
Europe (8919)
Florida (172)
Georgia (49)
Idaho (1)
Illinois (91)
India (3)
Indiana (51)
Japan (21)
Kansas (43)
Kentucky (2)
Maine (5)
Maryland (164)
Massachusetts (882)
Michigan (41)
Minnesota (66)
Missouri (3)
Montana (1)
Nebraska (5)
Nevada (10)
New Hampshire (19)
New Jersey (522)
New York (571)
North Carolina (111)
Northern California (660)
Ohio (14)
Oregon (2)
Pennsylvania (416)
Rhode Island (7)
South America (170)
South Carolina (2)
Southern California (590)
Tennessee (31)
Texas (234)
Utah (10)
Virginia (42)
Washington D.C. (16)
Washington State (126)
Wisconsin (2)
86,877 Results for "autism speaks".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
A New Era in Early Autism Support: LinusBio and Autism Speaks Partner to Promote Earlier Autism Diagnosis and Intervention
April 17, 2025
·
5 min read
Editorial
Kennedy’s Hunt for a Connection Between Vaccines and Autism Is a Sham
The Health and Human Services Secretary said that he will find and eliminate the cause of autism by September, an idea that suggests how little he knows about the condition.
April 17, 2025
·
3 min read
·
Dan Samorodnitsky
Press Releases
NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism
April 21, 2025
·
7 min read
Press Releases
LinusBio and The BRAIN Foundation Partner to Advance Biomarker-Supported Autism Diagnosis and Early Intervention
April 2, 2025
·
4 min read
Press Releases
Groundbreaking Autism Biomarker: LinusBio Launches ClearStrand-ASD to aid Health Care Providers in Ruling Out Autism Using a Single Strand of Hair
February 6, 2025
·
4 min read
FDA
Makary Discusses Expedited Rare Disease Approvals Pathway, ‘Public Distrust’ in New Interview
In an interview with former
Fox News
journalist Megyn Kelly, FDA Commissioner Marty Makary introduced a new mechanism-driven pathway that could be leveraged by rare disease therapies while saying that autism could potentially be driven by certain environmental factors.
April 21, 2025
·
2 min read
·
Tristan Manalac
Drug Development
As Autism Cases Rise, Biopharma Springs Into Action
Several companies—including Roche, Curemark and Yamo Pharmaceuticals—are running clinical trials of treatments that aim to offset the myriad challenges of autism.
April 25, 2024
·
6 min read
·
Tyler Patchen
Press Releases
Oryzon Announces Publication of Study on Phelan-McDermid Syndrome (PMS) Patients, a Form of Autism, Paving the Way for a Novel Personalized Medicine Approach with Vafidemstat
March 5, 2025
·
9 min read
Press Releases
Autism Spectrum Disorder Markets Expected to Exhibit a CAGR Of 5.84% During 2025-2035, impelled by Innovative Treatments
February 13, 2025
·
10 min read
Drug Development
STALICLA publishes pioneering phase 1b data on precision treatment for autism spectrum disorder in Biomedicines
STALICLA SA announced the publication of a landmark phase 1b study with STP1, a novel combination therapy tailored for the treatment of a clinically and biologically defined subgroup of patients with autism spectrum disorder, named ASD Phenotype 1.
June 27, 2024
·
3 min read
1 of 8,688
Next
